BRIEF-Tilray Canada-Entered Into Global Framework Agreement To Collaborate With Sandoz AG [Reuters]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Reuters
BRIEF-Tilray Canada-Entered Into Global Framework Agreement To Collaborate With Sandoz AG | Reuters 1 Min Read Dec 18 (Reuters) - Tilray Canada Ltd: * TILRAY CANADA - ENTERED INTO GLOBAL FRAMEWORK AGREEMENT TO COLLABORATE WITH SANDOZ AG TO INCREASE AVAILABILITY OF MEDICAL CANNABIS PRODUCTS ACROSS WORLD * TILRAY CANADA - AGREEMENT REPRESENTS INTENTIONS OF TWO COS TO OPERATE IN JURISDICTIONS WHERE CANNABIS IS OR WILL BE APPROVED FOR MEDICAL PURPOSES * TILRAY CANADA - SANDOZ AG MAY SUPPORT GLOBAL COMMERCIALIZATION OF TILRAY’S NON-SMOKABLE/NON-COMBUSTIBLE MEDICAL CANNABIS PRODUCTS * TILRAY CANADA - TILRAY AND SANDOZ AG MAY CO-BRAND CERTAIN NON-SMOKABLE/NON-COMBUSTIBLE PRODUCTS * TILRAY CANADA - TILRAY AND SANDOZ AG MAY COLLABORATE TO DEVELOP NEW MEDICAL CANNABIS PRODUCTS * TILRAY CANADA - MAY SUPPLY NON-SMOKABLE/ NON-COMBUSTIBLE MEDICAL CANNABIS PRODUCTS, LICENSE RIGHTS TO AND FROM SANDOZ AG IN RELATION TO SUCH PRODUCTS Source text for Eikon: Further company coverage: All quotes delayed
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug [Yahoo! Finance]Yahoo! Finance
- Evergreen Theragnostics Completes $26M Capital Raise to Advance Novel Radiopharmaceutical Pipeline into the Clinic, Prepare for First Commercial Product Launch, and Expand Industry-Leading CDMO Services [Yahoo! Finance]Yahoo! Finance
- New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN) [Yahoo! Finance]Yahoo! Finance
- New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)PR Newswire
- Food Allergy Pipeline Landscape Research Report 2024: Comprehensive Insights About 30+ Companies and 35+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 1/31/24 - Miss
NVS
Sec Filings
- 2/15/24 - Form S-8
- 2/2/24 - Form SC
- 1/31/24 - Form 6-K
- NVS's page on the SEC website